Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Others

Page Path

HOME
ARTICLE CATEGORY
Others

Correspondence

Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):1050-1051. Published online August 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0310

View: 154 Download: 6

Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”

Ji Young Ryu, Seon Ha Baek, Sejoong Kim

Clin Mol Hepatol. 2023;29(4):1048-1049. Published online August 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0261

View: 284 Download: 8

Special Review

Waiting for the changes after the adoption of steatotic liver disease

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):844-850. Published online September 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0291

View: 245 Download: 54

Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity

Gi-Ae Kim, Joon Ho Moon, Won Kim

Clin Mol Hepatol. 2023;29(4):831-843. Published online August 25, 2023

DOI: https://doi.org/10.3350/cmh.2023.0277

View: 487 Download: 114

Erratum

Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509]

Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Seok Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong

Clin Mol Hepatol. 2023;29(3):830-830. Published online April 13, 2023

DOI: https://doi.org/10.3350/cmh.2022.0345e
Corrects: Clin Mol Hepatol 2023;29(2):496

View: 774 Download: 14

Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]

Joo Hyun Oh, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(3):828-829. Published online April 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0054e
Corrects: Clin Mol Hepatol 2023;29(2):367

View: 711 Download: 15

Correspondence

Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Clin Mol Hepatol. 2023;29(3):823-824. Published online May 31, 2023

DOI: https://doi.org/10.3350/cmh.2023.0182

View: 862 Download: 32 Citation: 1

Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Clin Mol Hepatol. 2023;29(3):821-822. Published online May 31, 2023

DOI: https://doi.org/10.3350/cmh.2023.0183

View: 899 Download: 57

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”

Joo Hyun Oh, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(3):820-820. Published online May 19, 2023

DOI: https://doi.org/10.3350/cmh.2023.0135

View: 799 Download: 21

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”

Seul Ki Han, Soon Koo Baik, Moon Young Kim

Clin Mol Hepatol. 2023;29(3):817-819. Published online May 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0155

View: 840 Download: 33

Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”

Jeong-Ju Yoo, Sang Gyune Kim

Clin Mol Hepatol. 2023;29(2):513-515. Published online February 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0044

View: 1241 Download: 34

Special thanks

Seung Up Kim

Clin Mol Hepatol. 2023;29(Suppl):S4-S4. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0010

View: 1086 Download: 28

Preface

Yoon Jun Kim

Clin Mol Hepatol. 2023;29(Suppl):S2-S2. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0011

View: 1144 Download: 25

Preface

Seung Up Kim

Clin Mol Hepatol. 2023;29(Suppl):S3-S3. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0014

View: 1114 Download: 37

Congratulatory remarks

Si Hyun Bae

Clin Mol Hepatol. 2023;29(Suppl):S1-S1. Published online February 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0027

View: 1273 Download: 38

Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”

Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen

Clin Mol Hepatol. 2023;29(1):191-193. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0410

View: 1756 Download: 48

Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”

Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani

Clin Mol Hepatol. 2023;29(1):188-190. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0408

View: 2134 Download: 50 Citation: 1

Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”

Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn

Clin Mol Hepatol. 2023;29(1):185-187. Published online November 10, 2022

DOI: https://doi.org/10.3350/cmh.2022.0375

View: 1707 Download: 29

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”

Won Sohn, Yong-Han Paik

Clin Mol Hepatol. 2023;29(1):182-184. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0411

View: 1873 Download: 32

Erratum

Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]

Clin Mol Hepatol. 2022;28(4):940-940. Published online September 7, 2022

DOI: https://doi.org/10.3350/cmh.2022.0084.e1
Corrects: Clin Mol Hepatol 2022;28(2):276

View: 1836 Download: 45 Citations: 2

Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]

Do Young Kim

Clin Mol Hepatol. 2022;28(4):939-939. Published online June 24, 2022

DOI: https://doi.org/10.3350/cmh.2021.0277.e1
Corrects: Clin Mol Hepatol 2021;27(4):620

View: 1916 Download: 32

Special Topic

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline

Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim

Clin Mol Hepatol. 2021;27(4):515-523. Published online September 17, 2021

DOI: https://doi.org/10.3350/cmh.2021.0293

View: 4865 Download: 71 Citations: 6

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Hepatic Hippo signaling inhibits development of hepatocellular carcinoma

Yuchen Liu, Xiaohui Wang, Yingzi Yang

Clin Mol Hepatol. 2020;26(4):742-750. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0178

View: 6358 Download: 186 Citations: 30

Alcohol and hepatocarcinogenesis

Makiko Taniai

Clin Mol Hepatol. 2020;26(4):736-741. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0203

View: 4946 Download: 147 Citations: 14

Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights

Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina

Clin Mol Hepatol. 2020;26(4):728-735. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0202

View: 4758 Download: 170 Citations: 25

Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases

Yun Seok Kim, Sang Geon Kim

Clin Mol Hepatol. 2020;26(4):715-727. Published online September 22, 2020

DOI: https://doi.org/10.3350/cmh.2020.0173

View: 7459 Download: 240 Citations: 22

Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease

Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul

Clin Mol Hepatol. 2020;26(4):705-714. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0166

View: 3683 Download: 79 Citations: 6

Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell

Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong

Clin Mol Hepatol. 2020;26(4):697-704. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0152

View: 4763 Download: 129 Citations: 6

Emerging medical therapies for severe alcoholic hepatitis

David Tornai, Gyongyi Szabo

Clin Mol Hepatol. 2020;26(4):686-696. Published online September 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0145

View: 4931 Download: 196 Citations: 13

Roles of the complement system in alcohol-induced liver disease

Yi Zhou, Guandou Yuan, Fudi Zhong, Songqing He

Clin Mol Hepatol. 2020;26(4):677-685. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0094

View: 5478 Download: 130 Citations: 9

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

06 Days

*Last 12 months

Viewed By 7187	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 6213	A decade of liver organoids: Advances in disease modeling
Viewed By 4030	Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Viewed By 3392	MAFLD: How is it different from NAFLD?
Viewed By 3037	Hepatorenal syndrome: Current concepts and future perspectives

Cited By 117	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 54	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 52	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 46	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 46	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis